Optimising Pharmaceutical Products Using Formulation Science, Tablets & Capsules

By Kwok Chow, PhD, and Mark J Kontny, PhD


Approval of new drug products that treat unmet medical needs held steady or declined over the last decade.

Meanwhile, pharma companies continue to consolidate, R&D budgets continue to decline, and the cost of conducting late-stage clinical trials continues to escalate.

This article summarises techniques for formulating poorly water-soluble APIs and how selecting the right outsourcing partner can accelerate development.

Download to read more.

More About This Company